ERYDEL
Based in Urbino, EryDel has developed and patented a technology for drug delivery of pharmacological agents through erythrocytes (red blood cells). This process allow to easily load red blood cells with drugs, proteins, contrasting agents for diagnostic purposes, nanoparticles etc. that can be progressively released into the patient body thus allowing an increased efficacy of the therapy and a reduction of collateral effects. The benefit is extremely significant particularly for chronic pathol... ogies that requires continuous daily treatments for patients which could be substituted by monthly transfusion of blood loaded with specific therapeutic agents. Currently, the solution has been tested by several patients for the treatment of Inflammatory Bowel Diseases (IBDs) such as ulcer colitis and Crohn disease. The company can provide a complete support for the drug delivery process including a specific device for the erythrocytes loading ("Red Cell Loader"), and disposable kits.
ERYDEL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2007-02-01
Address:
San Giovanni, Molise, Italy
Country:
Italy
Website Url:
http://www.erydel.com
Total Employee:
11+
Status:
Active
Contact:
+39 02 36504470
Email Addresses:
[email protected]
Total Funding:
29 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Apache Microsoft Exchange Online Office 365 Mail
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Current Employees Featured
Founder
Investors List
Innogest Capital
Innogest Capital investment in Series B - Erydel
Genextra
Genextra investment in Series B - Erydel
Sofinnova Partners
Sofinnova Partners investment in Series B - Erydel
Innogest Capital
Innogest Capital investment in Series A - Erydel
FM Management
FM Management investment in Series A - Erydel
Official Site Inspections
http://www.erydel.com Semrush global rank: 6.69 M Semrush visits lastest month: 874
- Host name: 242.50.233.35.bc.googleusercontent.com
- IP address: 35.233.50.242
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Erydel"
Erydel - Crunchbase Company Profile & Funding
Erydel may be growing as it has been successfully acquired by Quince Therapeutics, which is a significant corporate development indicating a …See details»
Erydel Company Profile - Office Locations, Competitors, Revenue …
Erydel is a company that develops technology for drug delivery of pharmacological agents through red blood cells. Its proprietary platform technology is an automatic procedure to encapsulate …See details»
EryDel S.p.A. Information - RocketReach
EryDel is a multi-asset, clinical stage biopharmaceutical company headquartered in Bresso (Milan), Italy dedicated to developing and commercializing novel treatments for rare diseases …See details»
EryDel Company Profile 2024: Valuation, Investors, …
EryDel General Information Description. Developer of a non-invasive medical device and therapies designed to facilitate blood processing at the point of …See details»
Erydel - Products, Competitors, Financials, Employees, …
Erydel. Frequently Asked Questions (FAQ) When was Erydel founded? Erydel was founded in 2007. Where is Erydel's headquarters? Erydel's headquarters is located at Via A Meucci, 3, …See details»
EryDel SPA Company Profile | Management and Employees List
EryDel SPA Profile and History EryDel SpA is a biotechnology company specialized in the development of drugs delivered through red blood cells (RBCs) by using a proprietary medical …See details»
EryDel - Company Profile - Tracxn
Nov 6, 2024 EryDel ranks 5th among 266 active competitors. 84 of its competitors are funded while 32 have exited. Overall, EryDel and its competitors have raised over $1.61B in funding …See details»
EryDel S.p.A. Overview | SignalHire Company Profile
EryDel S.p.A. is a private company that has been in the industry for 43 years. The company currently specializes in the Biotechnology area. The position of the Co-Founder & CEO is …See details»
Erydel - Funding, Financials, Valuation & Investors - Crunchbase
Erydel develops technology for drug delivery of pharmacological agents through red blood cells. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much …See details»
EryDel SPA - Overview, News & Similar companies | ZoomInfo.com
Jul 24, 2023 EryDel to Present its Phase 3 Study Results for Ataxia Telangiectasia at the American Academy of Neurology 2022 Annual Meeting BRESSO (MILANO), ITALY / …See details»
ERYDEL SPA - Company Profile & Staff Directory - ContactOut
EryDel is a multi-asset, clinical stage biopharmaceutical company headquartered in Bresso (Milan), Italy dedicated to developing and commercializing novel treatments for rare diseases …See details»
EryDel S.p.A. - life-sciences-europe.com
Sep 21, 2013 Based in Milan, Italy, EryDel SpA is a biotechnology company specialized in the development of drugs delivered through red blood cells (RBCs) by using a proprietary medical …See details»
Erydel USA Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Erydel USA Inc. of Morganville, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Erydel - VentureRadar
Similar Companies: Neovacs SA France Publicly Traded Neovacs has two main activities: Research and Development activity, and investment activity. We are developing our own …See details»
Erydel - Company profile | ensun
Erydel Who is Erydel? We are dedicated to developing treatments utilizing our proprietary AIDE technology platform that hold the potential to help children and families affected by rare and …See details»
Erydel - Contacts, Employees, Board Members, Advisors & Alumni
Erydel has 4 current employee profiles, including Chief Executive Officer and Board Member Luca Benatti. Luca Benatti Chief Executive Officer and Board Member Mauro Magnani Founder & CSOSee details»
EryDel — Sofinnova Partners
EryDel S.p.A. specializes in the development of drugs and diagnostics delivered through human red blood cells via a proprietary medical device technology. Based in Milan, EryDel develops …See details»
EryDel DMF, CEP, Written Confirmations, FDF, Prices, Patents, …
EryDel is a multi-asset, clinical-stage biopharmaceutical company headquartered in Bresso (Milan), Italy dedicated to developing and commercializing novel treatments for rare diseases …See details»
Erydel - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Erydel uses 12 technology products and services including HTML5, Apache Server, and Google Fonts, according to G2 Stack. Erydel is actively using 15 technologies for its website, …See details»
EryDel Provides Regulatory Update on EryDex for the Treatment of …
Feb 22, 2023 EryDel SpA, a global late-stage biotech company aimed at developing and commercializing therapies for the treatment of rare diseases delivered by its proprietary red …See details»